Global Novel Drug Delivery Systems Market Size, Manufacturers, Opportunities and Forecast to 2030
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
According to APO Research, The global Novel Drug Delivery Systems market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Novel Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Drug Delivery Systems.
The Novel Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Novel Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Novel Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Novel Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Novel Drug Delivery Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Novel Drug Delivery Systems companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
According to APO Research, The global Novel Drug Delivery Systems market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Novel Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Drug Delivery Systems.
The Novel Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Novel Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Amgen
- Teva
- Roche
- UCB (Union Chimique Belge)
- Celgene
- Merck
- Gilead Sciences
- Sanofi
- Pfizer
- Takeda
- Bausch&Lomb
- Samyang Biopharmaceuticals
- Johnson & Johnson
- TOLMAR
- Astellas
- AMAG Pharmaceuticals
- AbbVie
- Dr Reddy
- AstraZeneca
- Aspen
- Acrotech Biopharma
- TWi Pharmaceuticals
- Liposomes
- PEGylated Proteins & Polypeptides
- Polymer Nanoparticle
- Protein–drug Conjugates
- Others
- Hospitals & Clinic
- Cancer Treatment Centers
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Novel Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Novel Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Novel Drug Delivery Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Novel Drug Delivery Systems companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Novel Drug Delivery Systems Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Novel Drug Delivery Systems Market Size by Region (2019-2030)
1.4.1 Global Novel Drug Delivery Systems Market Size by Region (2019-2024)
1.4.2 Global Novel Drug Delivery Systems Market Size by Region (2025-2030)
1.5 Key Regions Novel Drug Delivery Systems Market Size (2019-2030)
1.5.1 North America Novel Drug Delivery Systems Market Size Growth Rate (2019-2030)
1.5.2 Europe Novel Drug Delivery Systems Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Novel Drug Delivery Systems Market Size Growth Rate (2019-2030)
1.5.4 Latin America Novel Drug Delivery Systems Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Novel Drug Delivery Systems Market Size Growth Rate (2019-2030)
2 NOVEL DRUG DELIVERY SYSTEMS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Liposomes
2.1.2 PEGylated Proteins & Polypeptides
2.1.3 Polymer Nanoparticle
2.1.4 Protein–drug Conjugates
2.1.5 Others
2.2 Global Novel Drug Delivery Systems Market Size by Type
2.2.1 Global Novel Drug Delivery Systems Market Size Overview by Type (2019-2030)
2.2.2 Global Novel Drug Delivery Systems Historic Market Size Review by Type (2019-2024)
2.2.3 Global Novel Drug Delivery Systems Market Size Forecasted by Type (2025-2030)
2.3 Global Novel Drug Delivery Systems Market Size by Regions
2.3.1 North America Novel Drug Delivery Systems Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Novel Drug Delivery Systems Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Novel Drug Delivery Systems Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Novel Drug Delivery Systems Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Novel Drug Delivery Systems Market Size Breakdown by Type (2019-2024)
3 NOVEL DRUG DELIVERY SYSTEMS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Hospitals & Clinic
3.1.2 Cancer Treatment Centers
3.1.3 Others
3.2 Global Novel Drug Delivery Systems Market Size by Application
3.2.1 Global Novel Drug Delivery Systems Market Size Overview by Application (2019-2030)
3.2.2 Global Novel Drug Delivery Systems Historic Market Size Review by Application (2019-2024)
3.2.3 Global Novel Drug Delivery Systems Market Size Forecasted by Application (2025-2030)
3.3 Global Novel Drug Delivery Systems Market Size by Regions
3.3.1 North America Novel Drug Delivery Systems Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Novel Drug Delivery Systems Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Novel Drug Delivery Systems Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Novel Drug Delivery Systems Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Novel Drug Delivery Systems Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Novel Drug Delivery Systems Industry Trends
4.2 Novel Drug Delivery Systems Industry Drivers
4.3 Novel Drug Delivery Systems Industry Opportunities and Challenges
4.4 Novel Drug Delivery Systems Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Novel Drug Delivery Systems Revenue (2019-2024)
5.2 Global Novel Drug Delivery Systems Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Novel Drug Delivery Systems Key Company Headquarters & Area Served
5.4 Global Novel Drug Delivery Systems Company, Product Type & Application
5.5 Global Novel Drug Delivery Systems Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Novel Drug Delivery Systems Market CR5 and HHI
5.6.2 Global Top 5 and 10 Novel Drug Delivery Systems Players Market Share by Revenue in 2023
5.6.3 2023 Novel Drug Delivery Systems Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Amgen
6.1.1 Amgen Comapny Information
6.1.2 Amgen Business Overview
6.1.3 Amgen Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Amgen Novel Drug Delivery Systems Product Portfolio
6.1.5 Amgen Recent Developments
6.2 Teva
6.2.1 Teva Comapny Information
6.2.2 Teva Business Overview
6.2.3 Teva Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Teva Novel Drug Delivery Systems Product Portfolio
6.2.5 Teva Recent Developments
6.3 Roche
6.3.1 Roche Comapny Information
6.3.2 Roche Business Overview
6.3.3 Roche Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Roche Novel Drug Delivery Systems Product Portfolio
6.3.5 Roche Recent Developments
6.4 UCB (Union Chimique Belge)
6.4.1 UCB (Union Chimique Belge) Comapny Information
6.4.2 UCB (Union Chimique Belge) Business Overview
6.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Portfolio
6.4.5 UCB (Union Chimique Belge) Recent Developments
6.5 Celgene
6.5.1 Celgene Comapny Information
6.5.2 Celgene Business Overview
6.5.3 Celgene Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Celgene Novel Drug Delivery Systems Product Portfolio
6.5.5 Celgene Recent Developments
6.6 Merck
6.6.1 Merck Comapny Information
6.6.2 Merck Business Overview
6.6.3 Merck Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Merck Novel Drug Delivery Systems Product Portfolio
6.6.5 Merck Recent Developments
6.7 Gilead Sciences
6.7.1 Gilead Sciences Comapny Information
6.7.2 Gilead Sciences Business Overview
6.7.3 Gilead Sciences Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Gilead Sciences Novel Drug Delivery Systems Product Portfolio
6.7.5 Gilead Sciences Recent Developments
6.8 Sanofi
6.8.1 Sanofi Comapny Information
6.8.2 Sanofi Business Overview
6.8.3 Sanofi Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Sanofi Novel Drug Delivery Systems Product Portfolio
6.8.5 Sanofi Recent Developments
6.9 Pfizer
6.9.1 Pfizer Comapny Information
6.9.2 Pfizer Business Overview
6.9.3 Pfizer Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Pfizer Novel Drug Delivery Systems Product Portfolio
6.9.5 Pfizer Recent Developments
6.10 Takeda
6.10.1 Takeda Comapny Information
6.10.2 Takeda Business Overview
6.10.3 Takeda Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Takeda Novel Drug Delivery Systems Product Portfolio
6.10.5 Takeda Recent Developments
6.11 Bausch&Lomb
6.11.1 Bausch&Lomb Comapny Information
6.11.2 Bausch&Lomb Business Overview
6.11.3 Bausch&Lomb Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Bausch&Lomb Novel Drug Delivery Systems Product Portfolio
6.11.5 Bausch&Lomb Recent Developments
6.12 Samyang Biopharmaceuticals
6.12.1 Samyang Biopharmaceuticals Comapny Information
6.12.2 Samyang Biopharmaceuticals Business Overview
6.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Portfolio
6.12.5 Samyang Biopharmaceuticals Recent Developments
6.13 Johnson & Johnson
6.13.1 Johnson & Johnson Comapny Information
6.13.2 Johnson & Johnson Business Overview
6.13.3 Johnson & Johnson Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Johnson & Johnson Novel Drug Delivery Systems Product Portfolio
6.13.5 Johnson & Johnson Recent Developments
6.14 TOLMAR
6.14.1 TOLMAR Comapny Information
6.14.2 TOLMAR Business Overview
6.14.3 TOLMAR Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 TOLMAR Novel Drug Delivery Systems Product Portfolio
6.14.5 TOLMAR Recent Developments
6.15 Astellas
6.15.1 Astellas Comapny Information
6.15.2 Astellas Business Overview
6.15.3 Astellas Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Astellas Novel Drug Delivery Systems Product Portfolio
6.15.5 Astellas Recent Developments
6.16 AMAG Pharmaceuticals
6.16.1 AMAG Pharmaceuticals Comapny Information
6.16.2 AMAG Pharmaceuticals Business Overview
6.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 AMAG Pharmaceuticals Novel Drug Delivery Systems Product Portfolio
6.16.5 AMAG Pharmaceuticals Recent Developments
6.17 AbbVie
6.17.1 AbbVie Comapny Information
6.17.2 AbbVie Business Overview
6.17.3 AbbVie Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 AbbVie Novel Drug Delivery Systems Product Portfolio
6.17.5 AbbVie Recent Developments
6.18 Dr Reddy
6.18.1 Dr Reddy Comapny Information
6.18.2 Dr Reddy Business Overview
6.18.3 Dr Reddy Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.18.4 Dr Reddy Novel Drug Delivery Systems Product Portfolio
6.18.5 Dr Reddy Recent Developments
6.19 AstraZeneca
6.19.1 AstraZeneca Comapny Information
6.19.2 AstraZeneca Business Overview
6.19.3 AstraZeneca Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.19.4 AstraZeneca Novel Drug Delivery Systems Product Portfolio
6.19.5 AstraZeneca Recent Developments
6.20 Aspen
6.20.1 Aspen Comapny Information
6.20.2 Aspen Business Overview
6.20.3 Aspen Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.20.4 Aspen Novel Drug Delivery Systems Product Portfolio
6.20.5 Aspen Recent Developments
6.21 Acrotech Biopharma
6.21.1 Acrotech Biopharma Comapny Information
6.21.2 Acrotech Biopharma Business Overview
6.21.3 Acrotech Biopharma Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.21.4 Acrotech Biopharma Novel Drug Delivery Systems Product Portfolio
6.21.5 Acrotech Biopharma Recent Developments
6.22 TWi Pharmaceuticals
6.22.1 TWi Pharmaceuticals Comapny Information
6.22.2 TWi Pharmaceuticals Business Overview
6.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.22.4 TWi Pharmaceuticals Novel Drug Delivery Systems Product Portfolio
6.22.5 TWi Pharmaceuticals Recent Developments
7 NORTH AMERICA
7.1 North America Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Novel Drug Delivery Systems Market Size by Country (2019-2024)
7.3 North America Novel Drug Delivery Systems Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Novel Drug Delivery Systems Market Size by Country (2019-2024)
8.3 Europe Novel Drug Delivery Systems Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Country (2019-2024)
9.3 Asia-Pacific Novel Drug Delivery Systems Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Novel Drug Delivery Systems Market Size by Country (2019-2024)
10.3 Latin America Novel Drug Delivery Systems Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2019-2024)
11.3 Middle East & Africa Novel Drug Delivery Systems Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Novel Drug Delivery Systems Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Novel Drug Delivery Systems Market Size by Region (2019-2030)
1.4.1 Global Novel Drug Delivery Systems Market Size by Region (2019-2024)
1.4.2 Global Novel Drug Delivery Systems Market Size by Region (2025-2030)
1.5 Key Regions Novel Drug Delivery Systems Market Size (2019-2030)
1.5.1 North America Novel Drug Delivery Systems Market Size Growth Rate (2019-2030)
1.5.2 Europe Novel Drug Delivery Systems Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Novel Drug Delivery Systems Market Size Growth Rate (2019-2030)
1.5.4 Latin America Novel Drug Delivery Systems Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Novel Drug Delivery Systems Market Size Growth Rate (2019-2030)
2 NOVEL DRUG DELIVERY SYSTEMS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Liposomes
2.1.2 PEGylated Proteins & Polypeptides
2.1.3 Polymer Nanoparticle
2.1.4 Protein–drug Conjugates
2.1.5 Others
2.2 Global Novel Drug Delivery Systems Market Size by Type
2.2.1 Global Novel Drug Delivery Systems Market Size Overview by Type (2019-2030)
2.2.2 Global Novel Drug Delivery Systems Historic Market Size Review by Type (2019-2024)
2.2.3 Global Novel Drug Delivery Systems Market Size Forecasted by Type (2025-2030)
2.3 Global Novel Drug Delivery Systems Market Size by Regions
2.3.1 North America Novel Drug Delivery Systems Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Novel Drug Delivery Systems Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Novel Drug Delivery Systems Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Novel Drug Delivery Systems Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Novel Drug Delivery Systems Market Size Breakdown by Type (2019-2024)
3 NOVEL DRUG DELIVERY SYSTEMS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Hospitals & Clinic
3.1.2 Cancer Treatment Centers
3.1.3 Others
3.2 Global Novel Drug Delivery Systems Market Size by Application
3.2.1 Global Novel Drug Delivery Systems Market Size Overview by Application (2019-2030)
3.2.2 Global Novel Drug Delivery Systems Historic Market Size Review by Application (2019-2024)
3.2.3 Global Novel Drug Delivery Systems Market Size Forecasted by Application (2025-2030)
3.3 Global Novel Drug Delivery Systems Market Size by Regions
3.3.1 North America Novel Drug Delivery Systems Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Novel Drug Delivery Systems Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Novel Drug Delivery Systems Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Novel Drug Delivery Systems Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Novel Drug Delivery Systems Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Novel Drug Delivery Systems Industry Trends
4.2 Novel Drug Delivery Systems Industry Drivers
4.3 Novel Drug Delivery Systems Industry Opportunities and Challenges
4.4 Novel Drug Delivery Systems Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Novel Drug Delivery Systems Revenue (2019-2024)
5.2 Global Novel Drug Delivery Systems Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Novel Drug Delivery Systems Key Company Headquarters & Area Served
5.4 Global Novel Drug Delivery Systems Company, Product Type & Application
5.5 Global Novel Drug Delivery Systems Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Novel Drug Delivery Systems Market CR5 and HHI
5.6.2 Global Top 5 and 10 Novel Drug Delivery Systems Players Market Share by Revenue in 2023
5.6.3 2023 Novel Drug Delivery Systems Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Amgen
6.1.1 Amgen Comapny Information
6.1.2 Amgen Business Overview
6.1.3 Amgen Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Amgen Novel Drug Delivery Systems Product Portfolio
6.1.5 Amgen Recent Developments
6.2 Teva
6.2.1 Teva Comapny Information
6.2.2 Teva Business Overview
6.2.3 Teva Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Teva Novel Drug Delivery Systems Product Portfolio
6.2.5 Teva Recent Developments
6.3 Roche
6.3.1 Roche Comapny Information
6.3.2 Roche Business Overview
6.3.3 Roche Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Roche Novel Drug Delivery Systems Product Portfolio
6.3.5 Roche Recent Developments
6.4 UCB (Union Chimique Belge)
6.4.1 UCB (Union Chimique Belge) Comapny Information
6.4.2 UCB (Union Chimique Belge) Business Overview
6.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Portfolio
6.4.5 UCB (Union Chimique Belge) Recent Developments
6.5 Celgene
6.5.1 Celgene Comapny Information
6.5.2 Celgene Business Overview
6.5.3 Celgene Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Celgene Novel Drug Delivery Systems Product Portfolio
6.5.5 Celgene Recent Developments
6.6 Merck
6.6.1 Merck Comapny Information
6.6.2 Merck Business Overview
6.6.3 Merck Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Merck Novel Drug Delivery Systems Product Portfolio
6.6.5 Merck Recent Developments
6.7 Gilead Sciences
6.7.1 Gilead Sciences Comapny Information
6.7.2 Gilead Sciences Business Overview
6.7.3 Gilead Sciences Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Gilead Sciences Novel Drug Delivery Systems Product Portfolio
6.7.5 Gilead Sciences Recent Developments
6.8 Sanofi
6.8.1 Sanofi Comapny Information
6.8.2 Sanofi Business Overview
6.8.3 Sanofi Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Sanofi Novel Drug Delivery Systems Product Portfolio
6.8.5 Sanofi Recent Developments
6.9 Pfizer
6.9.1 Pfizer Comapny Information
6.9.2 Pfizer Business Overview
6.9.3 Pfizer Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Pfizer Novel Drug Delivery Systems Product Portfolio
6.9.5 Pfizer Recent Developments
6.10 Takeda
6.10.1 Takeda Comapny Information
6.10.2 Takeda Business Overview
6.10.3 Takeda Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Takeda Novel Drug Delivery Systems Product Portfolio
6.10.5 Takeda Recent Developments
6.11 Bausch&Lomb
6.11.1 Bausch&Lomb Comapny Information
6.11.2 Bausch&Lomb Business Overview
6.11.3 Bausch&Lomb Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Bausch&Lomb Novel Drug Delivery Systems Product Portfolio
6.11.5 Bausch&Lomb Recent Developments
6.12 Samyang Biopharmaceuticals
6.12.1 Samyang Biopharmaceuticals Comapny Information
6.12.2 Samyang Biopharmaceuticals Business Overview
6.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Portfolio
6.12.5 Samyang Biopharmaceuticals Recent Developments
6.13 Johnson & Johnson
6.13.1 Johnson & Johnson Comapny Information
6.13.2 Johnson & Johnson Business Overview
6.13.3 Johnson & Johnson Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Johnson & Johnson Novel Drug Delivery Systems Product Portfolio
6.13.5 Johnson & Johnson Recent Developments
6.14 TOLMAR
6.14.1 TOLMAR Comapny Information
6.14.2 TOLMAR Business Overview
6.14.3 TOLMAR Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 TOLMAR Novel Drug Delivery Systems Product Portfolio
6.14.5 TOLMAR Recent Developments
6.15 Astellas
6.15.1 Astellas Comapny Information
6.15.2 Astellas Business Overview
6.15.3 Astellas Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Astellas Novel Drug Delivery Systems Product Portfolio
6.15.5 Astellas Recent Developments
6.16 AMAG Pharmaceuticals
6.16.1 AMAG Pharmaceuticals Comapny Information
6.16.2 AMAG Pharmaceuticals Business Overview
6.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 AMAG Pharmaceuticals Novel Drug Delivery Systems Product Portfolio
6.16.5 AMAG Pharmaceuticals Recent Developments
6.17 AbbVie
6.17.1 AbbVie Comapny Information
6.17.2 AbbVie Business Overview
6.17.3 AbbVie Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 AbbVie Novel Drug Delivery Systems Product Portfolio
6.17.5 AbbVie Recent Developments
6.18 Dr Reddy
6.18.1 Dr Reddy Comapny Information
6.18.2 Dr Reddy Business Overview
6.18.3 Dr Reddy Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.18.4 Dr Reddy Novel Drug Delivery Systems Product Portfolio
6.18.5 Dr Reddy Recent Developments
6.19 AstraZeneca
6.19.1 AstraZeneca Comapny Information
6.19.2 AstraZeneca Business Overview
6.19.3 AstraZeneca Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.19.4 AstraZeneca Novel Drug Delivery Systems Product Portfolio
6.19.5 AstraZeneca Recent Developments
6.20 Aspen
6.20.1 Aspen Comapny Information
6.20.2 Aspen Business Overview
6.20.3 Aspen Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.20.4 Aspen Novel Drug Delivery Systems Product Portfolio
6.20.5 Aspen Recent Developments
6.21 Acrotech Biopharma
6.21.1 Acrotech Biopharma Comapny Information
6.21.2 Acrotech Biopharma Business Overview
6.21.3 Acrotech Biopharma Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.21.4 Acrotech Biopharma Novel Drug Delivery Systems Product Portfolio
6.21.5 Acrotech Biopharma Recent Developments
6.22 TWi Pharmaceuticals
6.22.1 TWi Pharmaceuticals Comapny Information
6.22.2 TWi Pharmaceuticals Business Overview
6.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue, Global Share and Gross Margin (2019-2024)
6.22.4 TWi Pharmaceuticals Novel Drug Delivery Systems Product Portfolio
6.22.5 TWi Pharmaceuticals Recent Developments
7 NORTH AMERICA
7.1 North America Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Novel Drug Delivery Systems Market Size by Country (2019-2024)
7.3 North America Novel Drug Delivery Systems Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Novel Drug Delivery Systems Market Size by Country (2019-2024)
8.3 Europe Novel Drug Delivery Systems Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Novel Drug Delivery Systems Market Size by Country (2019-2024)
9.3 Asia-Pacific Novel Drug Delivery Systems Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Novel Drug Delivery Systems Market Size by Country (2019-2024)
10.3 Latin America Novel Drug Delivery Systems Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2019-2024)
11.3 Middle East & Africa Novel Drug Delivery Systems Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
